Ariane Ribeiro de Freitas Rocha*
Nubia de Souza de Morais
Francilene Maria Azevedo
Dayane de Castro Morais
Patrícia Feliciano Pereira
Maria do Carmo Gouveia Peluzio
Sylvia do Carmo Castro Franceschini
Silvia Eloiza Priore
- Department of Nutrition and Health, Federal University of Viçosa, Viçosa, Brazil
Introduction: Adipose tissue is important in the secretion of inflammatory substances, and may be directly or indirectly associated to the development of cardiovascular and metabolic diseases in adolescence.
Objective: To evaluate whether inflammatory markers are associated to body fat percentage in adolescents.
Methodology: Systematic review conducted following the items of the PRISMA, and registered in PROSPERO. The descriptors adolescent, body fat distribution and cytokines were combined together in the electronic databases: Scopus, PubMed, Embase, Cochrane, Scholar Google and ProQuest, independently by two researchers, in January 2022 and atualized in November 2024. Meta-analysis of the correlation of inflammatory markers with body fat percentage was conducted using the metabin function of the meta package of the RStudio software (4.0.4).
Results: Resulted in 7,592 records, of which 31 articles met the inclusion criteria and were selected for this study. Cross-sectional and prospective cohort observational studies were included. The meta-analysis included 4,682 adolescents, aged 10 to 19 years, of both sexes. The inflammatory markers leptin and C-reactive protein were positively correlated (r = 0.67; r = 0.32) and adiponectin was negatively correlated (r = −0.23) with body fat percentage in adolescents of both sexes.
Conclusion: In adolescents, the body fat percentage is related to the inflammatory markers leptin, C-reactive protein and adiponectin. It is important to evaluate the body fat composition of adolescents in clinical practice to identify those with a higher percentage of fat, that may reflect an inflammatory profile, as well as increased cardiometabolic risk that accompanies adolescents into adulthood.
Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42020208305, identifier PROSPERO: CRD42020208305.
Graphical Abstract.
Introduction
Adolescence is the chronological period between the ages of 10 and 19 years, which includes important physical and psychosocial changes that lead to grow and develop (1, 2). Behavioral changes during this period can promote unhealthy habits, such as a sedentary lifestyle and poor diet, which, together with genetic and physiological components, are risk factors for overweight and obesity (3–5).
Obesity has affected adolescents all over the world. It is the most prevalente chronic non-communicable disease in these individuals (6). Body mass index (BMI) is the most widely used indicator to identify obesity, but it is unable to differentiate adipose tissue from fat-free tissue, and can significantly underestimate the prevalence of obesity. For adolescents, it has the important limitation of not using cut-off points established on the basis of prognosis of morbidity or mortality, unlike adults. In addition, the BMI cutoff points in adolescents are not correlated with the biological outcomes and do not take into account the association between sexual maturation and anthropometric measurements (3). Therefore, it is necessary to assess the body fat composition of adolescents, since percentages equal to or greater than 20% in males and 25% in females are associated with high cardiometabolic risk in these individuals (7). In addition, adolescents classified as having a normal BMI may have a body fat percentage (%BF) above normal and be at a similar risk to those with obesity (high BMI and high %BF) of developing cardiometabolic diseases (8–14).
The production and secretion of inflammatory cytokines tends to be higher in adults with a high body fat percentage (15) because adipose tissue, in addition to storing energy, regulating temperature and providing mechanical protection, is a dynamic organ that secretes pro-inflammatory and anti-inflammatory, involved in the process of subclinical inflammation (16). Excess adipose tissue can both release direct markers of inflammation, such as adiponectins and leptins, as well as cytokines involved in the synthesis of other markers, such as adipocytes involved in the stimulation of hepatic C-reactive protein (CRP) synthesis. Thus, the increase in adipose tissue results in macrophage infiltration and increased levels of inflammatory substances in the tissue and circulation, which are directly or indirectly associated to the development of cardiovascular and metabolic diseases in these individuals (17, 18).
It remains to be seen whether this also applies to adolescents, mainly because we believe that at this stage of life, the higher the percentage of body fat, the higher the levels of inflammatory markers. And that this inflammation may be present even before the development of cardiometabolic complications, being an important risk factor that can continue or worsen in adult life. In this sense, the objective of this review was to evaluate whether inflammatory markers are associated to body fat percentage in adolescents.
Methodology
Data source and research strategy
This systematic review was conducted following the items of the Preferred Reporting Items for Systematic Reviews – PRISMA (19) and registered with PROSPERO under number CRD42020208305.
The Population, Exposure, Comparator, and Outcomes (PECOS) method was adopted for the inclusion criteria, to answer whether inflammatory markers are associated with body fat percentage in adolescents. The population consisted of adolescents aged 10–19 years; exposure was body fat percentage; there was no comparison; the expected outcome was the presence of inflammatory markers; and cross-sectional and prospective cohort studies were included.
The research considered all inflammatory markers related to body fat in adolescents, secreted or not by adipocytes, in order to verify the role of body fat in the development of subclinical inflammation in the body. Moreover, uric acid, even not being characterized as a marker of inflammation, was also included in this review because, although its important role as an antioxidant in the circulation is known, in increased levels, such as above 5 mg/dL. In addition, uric acid, although not characterized as an inflammation marker, was also included in this review because, although its important role as an antioxidant in the circulation is known, at increased levels, such as above 5 and 8 mg/dL (20) for women and men, respectively, it is strongly related to metabolic complications associated with fat tissue.
All methods of body fat assessment were considered to obtain a larger number of studies, since in the published studies there is high heterogeneity in the choice of methods.
The search for articles was carried out in January 2022, and update in November 2024, in the electronic databases: Scopus, PubMed, Embase, Cochrane, Scholar Google and ProQuest. Rayyan bibliographic software was used to store the references. The steps were performed without a filter, using different combinations of the Medical Subject Headings (MeSH) and Health Sciences Descriptors (DecS), namely: adolescent, body fat distribution and cytokines. The complete search strategy is available in Supplementary material—Appendix I.
Selection of studies
The steps for the search (Figure 1) were performed independently by two reviewers, using the Rayyan software (Qatar Computing Research Institute, Qatar). A search for articles was carried out in the databases, checking the total number found; exclusion of duplicate; title reading for initial selection; subsequent selection for reading the abstracts. Finally, the complete analysis to verify which studies met the eligibility criteria. The included and excluded studies were determined by consensus among the reviewers. A reverse search was performed, which consists of analyzing the references of the selected articles to identify studies that were not included in the databases, but no study of interest was found.
Figure 1. Flowchart of articles selected in the systematic review.
Eligibility criteria
Original articles from studies that evaluated the correlation between the presence of inflammatory markers and body fat percentage in adolescents aged 10–19 years were included. To ensure greater scope in the research, there was no language distinction or restriction on the time of publication of the studies. Studies involving adolescents undergoing surgery, such as stomach reduction, who were in a weight loss program, and/or those with any comorbidity (except obesity) were not included. Review articles, experimental studies, guidelines, theses, dissertations and abstracts, as well as studies that did not meet the aforementioned inclusion criteria, were also excluded.
Data analysis and extraction
He extracted data were organized in a Microsoft Excel (Microsoft Corp., Washington, United States) spreadsheet and included: title, authors, place of performance, year of publication, study design, objective, characteristics of the individuals, sample size, measurements of body fat percentage, inflammatory markers and main results (Table 1). The primary outcome was the presence of inflammatory markers associated with body fat percentage in adolescents. Data are presented in ascending order of year of publication.
Meta-analysis
Articles that presented correlation coefficients between body fat percentage and inflammatory markers were included in the meta-analysis. The generic inverse variance clustering method was used to combine correlations from different studies into a clustered correlation estimate (21). Correlations were systematized and meta-analysis was performed using RStudio software (Posit software, PBC, Boston, MA, United States) version 4.0.4 with the metabin function included in the meta package. with the metabin function included in the meta package. In addition, the information was plotted on a florestplot (22). To detect studies that contributed to heterogeneity, the effect graph of each study was evaluated with the Influence Analysis function of the meta package (23). The heterogeneity between the studies was quantified by means of proportion (by the I2 statistic), in which values above 25, 50, and 75% are considered low, moderate and high heterogeneity, respectively. The level of statistical significance established was p < 0.05.
Risk of bias assessment
The risk of bias was independently assessed by the critical assessment tool recommended by the Joanna Briggs Institute, by two researchers, with the aid of the checklist (Supplementary material—Appendix II) for cross-sectional studies, composed of 08 questions (24), and for cohort studies, consisting of 11 questions, which can be answered as: yes, no, unclear or not applicable. “Yes” answers indicate a low risk of bias, and “no” answers are expected to be high risk of bias.
Review quality assessment
The quality of this systematic review was evaluated according to the Assessment of Multiple Systematic Reviews, AmStar, method. This approach considers several key aspects, including the definition of the central question of the review, the inclusion criteria, and peer assessment of researchers. Procedures for consensus decision in case of disagreements in the inclusion or exclusion of articles, and broad search considering different bases and gray literature sources. Additionally, characterization and quality assessment of included studies, methods used to combine study findings, probability of bias in published results, and possible conflicts of interest (25).
Results
Figure 1 presents the detailed flowchart of the selection of studies, according to the PRISMA protocol. The search identified 7,592 articles, and after selection, 31 studies were included, representing 29 cross-sectional and two prospective cohorts.
Description of studies
The articles included in the review were published from 1998 to 2022 and carried out in different locations: Brazil (9, 11, 20, 26–31); EUA (30–34); Taiwan (35–38); India (39); Spain (40, 41); Iran (42, 43); Greece (44); Poland (45, 46); South Afica (47, 48); Denmark (49); Finland (50); Iceland (51); and Portugal (52). The sample size ranged from 27 (32) a 3,877 (28) and the age of the adolescents evaluated was from 10 to 19 years old, comprising the entire age group age group that involves adolescence (53). Individuals of both sexes were evaluated in most studies: seven female (9, 27, 29, 37, 43, 44, 46, 50) and one male (38) (Table 1).
Table 1. Characteristics of the selected studies.
Main results
The studies used different techniques to assess the body fat percentage (%BF): bioimpedance (9, 20, 32, 38, 39, 41–44, 46, 52); dual energy X-ray absorptiometry (DEXA) (20, 26, 27, 29–31, 33–36, 40, 50, 51, 54); air displacement plethysmography (11, 28, 47, 48); sum of the four skinfolds (49); and infrared interactance (Futrex) (45). Each of these methods has advantages and disadvantages, with DEXA and air displacement plethysmography being considered the gold standard, however, they are expensive methods that are not widely available. Bioimpedance, despite being widely used for its practicality, speed, and for being non-invasive, varies according to the individual’s hydration, which can lead to under- or overestimation of the body fat value. Infrared ray interactance is fast, safe, and non-invasive, however, it is less specific than other methods, especially in cases of excess adiposity. The sum of the four folds is a simple, low cost method, however, it requires a highly trained examiner.
The inflammatory markers evaluated were: CRP (9, 11, 27, 28, 30, 31, 33, 39, 40, 42, 43, 47, 49, 51); leptin (9, 26, 27, 29, 32–34, 36, 37, 41, 44–46, 48, 50, 54); adiponectin (28, 30, 31, 33–35, 39, 41, 52); tumor necrosis factor-α (TNF-α) (11, 27, 29, 30, 40, 47, 49); interleukin-6 (IL-6) (11, 27–30, 33, 40, 47, 49); interleukin-10 (IL-10) (29), considered mediators of inflammation, secreted by adipose tissue or by other organs, through the stimulation of pro-inflammatory cytokines secreted by adipocytes, such as CRP, synthesized by hepatocytes by stimulation of IL-6 and TNF-α. Also, uric acid was evaluated (20, 38) which, although not a marker of inflammation, at high levels, such as above 5 mg/dL, is involved in metabolic complications associated with adipose tissue.
Despite the various markers described in the researched literature, only CRP (27, 30, 31, 33, 39, 40, 42, 43, 51); leptin (9, 26, 27, 32–34, 36, 41, 44–46, 48); IL-6 (33); and adiponectin (31, 33, 35, 39) were correlated with %BF in the adolescentes of the studies included in this review (Table 1).
The meta-analysis included 4,682 adolescents, aged 10–19 years, of both sexes. The systematization included three markers: CRP, leptin and adiponectin. Analyes were performed by sex, but there was no significant result due to the low number of studies that had correlation data separated by sex, showing that it was not a mediating factor. The correlation between %BF and leptin was 0.67 (95%CI: 0.58; 0.75), heterogeneity of 91%, and with CRP it was 0.32 (95%CI: 0.20; 0.43), heterogeneity of 79%. The result of the randomized model was considered, due to the high heterogeneity presented in the two correlations. For adiponectin, the correlation was −0.23 (95%CI: −0.31; −0.14), heterogeneity of 0%, considering the result of the fixed effect, given its low heterogeneity (I2 = 0) (Figure 2).
Figure 2. Forestplot for correlation coefficients between body fat percentage and Leptin (A), CRP (B) and Adiponectin (C) in adolescents. This figure represents the individual effect of each study and the size indicates the sample weight; The black line represents the confidence interval (CI) of each study; The diamond systematizes the correlation between the inflammatory marker and the percentage of fat from all studies and the horizontal edges indicate the CI.
Despite the high heterogeneity for the first two analyses, all studies included in the meta-analysis showed a positive correlation, corroborating the systematized result. Examining the influence graph, it is evident that the exclusion of any study is capable of significantly reducing heterogeneity (Supplementary material—Appendix III).
In addition, it was considered in the meta-analysis whether the methods of %BF assessment influenced the outcomes of inflammation. Significant results were found only for leptin and CRP. The correlation coefficient between %BF and leptin and between %BF and CRP were higher when the method used to assess fat was densitometry, compared to bioimpedance, with high heterogeneity in both analyses (Supplementary material—Appendix IV).
Finally, systematization of the correlation between BMI and the variables leptin, CRP and adiponectin was also performed, and it was observed that the correlation between BMI and CRP was 0.30 (95%CI: 0.24; 0.36), heterogeneity of 28%; with leptin it was 0.56 (95%CI; 0.46; 0.64), heterogeneity of 76%; and with adiponectin it was −0.20 (95% CI; −0.27; −0.13), 0% heterogeneity. These results confirm the superiority of the percentage of body fat to predict the responses of inflammatory markers, when compared to BMI, indicating the importance of its evaluation in clinical practice (Supplementary material—Appendix V).
Risk of bias assessment
Most studies were of the cross-sectional type, with two of the prospective cohort type (45, 50). Therefore, the risk of bias was assessed using two tools: one for cross-sectional and the other for cohort. All had validly and reliably measured exposure and results, valid objective and measurement criteria, and appropriate statistical analysis. Sixteen (51.6%) did not describe in detail the individuals and the evaluated environment, and twelve (38.7%) did not identify confounding factors. Despite this, the articles included in this review showed 82.3% of the answers as “yes” in the critical assessment recommended by the Joanna Briggs Institute for cross-sectional studies. And 81.8% for cohort studies, as shown in Figures 3, 4, respectively, which indicates a low risk of bias, according to Moola et al. (24) (Supplementary material—Appendix II).
Figure 3. Risk of bias assessment, according to the Joanna Briggs Institute critical assessment checklist, for cross-sectional studies. 1. Criteria for inclusion in the sample cleary defined; 2. Study subjects and the setting described in detail; 3. Exposure measured in a valid and reliable way; 4. Objective and standard criteria for measurement; 5. Confounding factors identified; 6. Strategies to deal with confounding factors; 7. Outcomes measured in a valid and reliable way; 8. Appropriate statically analysis.
Figure 4. Risk of bias assessment, according to the Joanna Briggs Institute critical assessment checklist, for cohort studies. 1. Similar groups recruited from the same population; 2. Exposures in a similar way to designate as persons to exposed and unexposed groups; 3. Validly and reliably measured exposure; 4. Identification factors; 5 Strategies for dealing with confounders; 6. Groups were free/participating at baseline (or at time of exposure); 7. Intermediate results validly and reliably; 8. Follow-up time was observed and sufficient for results to occur; 9. Follow-up was complete and, if not, reasons for loss of follow-up were described and exploratory; 10. Strategies were used to address incomplete follow-up; 11. Appropriate statistics.
Review quality assessment
All criteria proposed by the method used for quality assessment were met in this review (25) (Supplementary material—Appendix VI).
Discussion
This review presents a systematization of published articles on inflammation and body fat composition in adolescents, and evidences a strong correlation of the inflammatory markers CRP, leptin and adiponectin with the body fat percentage in adolescents, portrayed by the result of the meta-analysis. Despite the high heterogeneity of the studies, justified by the inclusion of different ethnic populations, as well as by different techniques for assessing body fat, we can consider this result important to describe the relationship between the inflammatory profile of adolescents and adiposity.
The main results of the studies included (9, 11, 20, 26–52, 54) in this review showed that the body fat percentage is positively associated with the presence of inflammatory markers leptin, adiponectin, CRP and IL-6 in adolescents of both sexes, and that the higher the percentage of fat, the higher the level of these markers. Furthermore, the chance of presenting hyperuricemia is greater in adolescents with a high percentage of body fat.
Obesity, resulting from positive energy balance, is characterized by increased white adipose tissue, associated with hypertrophy or even hyperplasia of white adipocytes. This abnormal increase is associated with systemic metabolic changes such as hyperglycemia, insulin resistance and dyslipidemias. In addition, white adipose tissue is currently considered a metabolically active organ, of endocrine nature, responsible for the expression and/or secretion of adipokines and other inflammatory proteins, which act locally or systemically, thus characterizing the inflammation present in excess adiposity (16).
In the initial periods of excess caloric intake, the organism performs a physiological expansion of white adipose tissue with the secretion of acute proinflammatory mediators that will modulate triglyceride deposits in order to avoid ectopic fat accumulation. This process is necessary and physiologically adaptive. However, when a prolonged positive energy balance occurs, obesity progresses and this process is suppressed, resulting in metabolic stress, with a low-grade chronic inflammatory state, with various pathological consequences (55, 56).
Although it is not known exactly what the primary stimulus for inflammation associated adipose tissue is, it is known that there are several metabolic processes involved in hypertrophy and hyperplasia in excess of adipose cells resulting from excessive caloric intake. Among these processes, there is fibrosis and mechanical stress caused by the rapid expansion of adipocytes. Also, there are: hypoxia resulting from insufficient vascularization of the expanding white adipose tissue, the death of adipocytes due to their inability to store the fat and glucose overload, and the infiltration of macrophages, which account for 60% of obesity adipose tissue cells. As well as the high levels of lipopolysaccharides in the circulation derived from the intestinal microbiota, due to the excess of lipid absorption in the enterocytes and the compromise of the intestinal barrier (55, 57, 58).
The expansion of adipose tissue causes inflammatory changes that lead to low-grade systemic inflammation, with increased levels of cytokines. The accumulation of inflammatory cells occurs more due to the accumulation of visceral fat than of subcutaneous fat. This inflammation differs from that normally used against invading hosts of the organism because it is chronic, low-grade, and affects the metabolism of nutrients in adipose, hepatic, muscular and pancreatic tissue. This is because it promotes insulin resistance, which is a link between obesity and inflammation (16).
The studies presented here showed that the inflammatory markers correlated with a high body fat percentage are IL-6, leptin, CRP and adiponectin. IL-6 is secreted by adipocytes due to excessive lipolysis and an increase in free fatty acids, so that excess visceral fat increases the levels of this cytokine by 2–3 times (59). It is involved in the processes of carbohydrate and lipid metabolism, leading to hyperinsulinemia, by altering the expression of insulin receptors, and increasing levels of fatty acids and glycerol, by inhibiting lipoprotein lipase and increasing lipolysis (60–62). In adolescentes with obesity, high concentrations of IL-6 have been a reflection of a proinflammatory and prothrombotic state (63), being strongly associated with the presence of insulin resistance (64). Even in eutrophic adolescents, but with a high %BF, IL-6 was correlated with other inflammatory cytokines, such as TNF-α and with the development of insulin resistance (8) as well as, with modulating the synthesis of CRP, showing the role of adipose tissue in inflammation.
Leptin, an important adipokine, acts on molecular pathways such as PI3K/AKT and mTOR is encoded by the obesity gene and is involved in the process of regulating food intake. When fat tissue, especially visceral fat, is in excess, there is also an excess of these cytokines and, in response, the body, via the central nervous system, promotes resistance to their action, exacerbating obesity and leading to hyperglycemia and insulin resistance (65).
In adolescents, leptin has shown a strong correlation with all body fat parameters, mediating the relationship between body adiposity and blood pressure elevation in adolescents of both sexes (66). In females, there is a greater number of significant correlations between leptin and cardiometabolic risk factors (67).
Another important adipokine is adiponectin, which has an anti-inflammatory role in tissues, and acts as an insulin sensitizer. It has reduced levels in obesity, which compromises the activation of AMP kinase and worsens metabolic dysfunction, promoting a insulin resistance, liver fibrosis and, consequently, inflammation (68). Adiponectin in adolescents was correlated with obesity, insulin resistance and hyperlipidemia (69), as well as the presence of metabolic syndrome in these individuals (70).
C-reactive protein (CRP) is an inflammation marker synthesized by hepatocytes, which also has its production regulated by other cytokines, such as TNF-α and IL-6, produced by adipocytes. It is an acute phase protein involved in system activation, complement and phagocytic cell recruitment (71, 72). In adolescents, CRP was positively correlated with measures of body and visceral adiposity (63), and also with insulin resistance in adipose tissue (64, 73). This suggests that the increase in CRP occurs due to the inflammatory state of obesity, and may be an important indicator in the diagnosis of cardiovascular and metabolic complications in adolescent (74).
With regard to uric acid, the end product of purine metabolism, it is associated with chronic inflammation of adipose tissue (75). Its evaluation is important because, when elevated, at levels above 5 mg/dL, it is associated with cardiometabolic complications from an early age (76). In adolescents, insulin, fasting glucose, blood pressure and %BF values have been significantly higher in those with hyperuricemia (75, 76).
Epigenetic alterations in genes associated with the inflammatory markers discussed, such as leptin, C-reactive protein, and adiponectin, play a crucial role in pediatric obesity. These alterations, including DNA methylation and histone modifications, modulate the expression of inflammatory cytokines, contributing to a sustained inflammatory state and perpetuating an adverse metabolic profile. Such mechanisms are closely linked to the activation of the NF-κB pathway, a key regulator of pro-inflammatory gene expression in adipose tissue and other target organs. This intricate interplay between epigenetic changes and inflammatory pathways highlights the molecular basis of the elevated cardiometabolic risk observed in adolescents with a higher body fat percentage, as demonstrated in the present study (77).
It is understood, therefore, that the dysfunction of adipose tissue with an increase in the inflammatory process is the central mechanism for the development of the many metabolic complications resulting from obesity, since it is a tissue that communicates with many other organs, releasing inflammatory molecules that affect the homeostasis of the whole organism (76). Thus, the analysis of the body fat percentage is necessary to understand the inflammatory profile of adolescents, since the use of BMI in the assessment of nutritional status does not allow the correct identification of fat mass, thus underestimating the prevalence of obesity (12–14). This is so, since more than a quarter of adolescents with a high %BF are classified as eutrophic when using only this index (78). Thus, given the strong correlation between inflammatory markers and %BF in adolescents, the importance of assessing body fat composition is reiterated as a form of early intervention useful for acquiring and maintaining current and future health.
Strengths and limitations
As strengths, it is believed that this is the first study to present a review on the subject specifically for adolescents, highlighting the novelty of this study in systematizing, through meta-analysis, the correlation of inflammatory markers with the percentage of body fat in these individuals. In addition, the studies included in this review were conducted with different populations, in 12 countries on different continents, evidencing the consistency of the data. Furthermore, the PRISMA Guideline was strictly followed to conduct this study and the Joanna Briggs Institute assessment tool confirmed the low risk of bias of the studies selected to compose the review. This study had limitations. There was no standardization in the method of assessing body fat composition, considering different procedures. All methods of body composition assessment were included, in order to broaden the inclusion of articles, due to the high heterogeneity in the choice of methods in already published studies. Body fat assessed by DEXA was shown to have a higher correlation with the markers when compared to another method. DEXA is considered the gold standard in body composition assessment and therefore has higher accuracy in this estimation. However, it is an expensive method, and not very accessible in the clinical setting, which makes simpler methods, such as bioimpedance, practical options that can, in controlled situations, provide results very close to those provided by the gold standard. Similarly, anthropometric measures that estimate body composition, especially skinfolds, are viable options for this assessment if trained assessors are available. The cross-sectional nature of most studies implies the need for longitudinal analyses, since it does not allow verifying causal relationships and does not consider changes in the concentration of markers due to numerous factors over time.
Conclusion
This meta-analysis showed a significant correlation between high levels of leptin and CRP, and low levels of adiponectin, with body fat percentage in adolescents of both sexes. The Studies includes also showed that high levels of IL-6 and uric acid are associated with excess adiposity in these individuals. This highlights the need to routinely assess the body fat composition of adolescents, in order to identify those who have excess body fat, since they may present, at this stage of life, with chronic inflammation. This, in turn, may be the basis for the development of cardiometabolic diseases in adolescence, with maintenance or worsening in adulthood. This is especially important in the context of public health, in order to direct disease prevention and health promotion actions.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
AR: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing. NM: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing. FA: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing. DM: Conceptualization, Formal Analysis, Supervision, Visualization, Writing – review & editing. PP: Supervision, Visualization, Writing – review & editing. MP: Supervision, Visualization, Writing – review & editing. SF: Supervision, Visualization, Writing – review & editing. SP: Supervision, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author declare that financial support was received for the research and/or publication of this article. This study was funded by the Research Support Foundation of the State of Minas Gerais (FAPEMIG) (process no. APQ-03016-23).
Acknowledgments
The authors thank the CAPES Foundation, the Minas Gerais State Research Foundation (FAPEMIG, Brazil), and the National Council for Scientific and Technological Development (CNPq, Brazil).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2025.1560080/full#supplementary-material
References
1. World Health Organization (WHO). Nutrition in Adolescence: Issues and Challenges for the Health Sector: Issues in Adolescent Health and Development. Geneva: WHO (2005).
2. Ministry of Health. Department of Programmatic and Strategic Actions. Protecting and Caring for the Health of Adolescents in Primary Care. Ministry of Health, Secretariat of Health Care, Department of Programmatic and Strategic Actions. 2nd ed. Brasília: Ministry of Health (2018).
3. Priore S, Faria F, Franceschini S. Adolescence. In: Priore SE, et al. editors. Nutrição e Saúde na Adolescência. Rio de Janeiro: Rúbio (2010). p. 1–7.
4. Flores L, Gaya A, Petersen R, Gaya A. Tendência do baixo peso, sobrepeso e obesidade de crianças e adolescentes brasileiros. J Pediatr. (2013) 89:456–61. doi: 10.1016/j.jped.2013.02.021
5. Barbalho, E, Pinto F, Silva F, Sampaio R, Dantas D. Influência do consumo alimentar e da prática de atividade física na prevalência do sobrepeso/obesidade em adolescentes escolares. Caderno de Saúde Coletiva. (2020) 28:12–23. doi: 10.1590/1414-462X202028010181
6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975-2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents and adults. Lancet. (2017) 390:2627–42. doi: 10.1016/S0140-6736(17)32129-3
7. Williams D, Going S, Lohman T, Harsha D, Srinivasan S, Webber L, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. (1992) 82:358–63. doi: 10.2105/ajph.82.3.358
8. Carvalho G, Pereira P, Serrano H, do Carmo Castro Franceschini S, Oliveira de Paula S, Priore SE, et al. Peripheral expression of inflammatory markers in overweight female adolescents and eutrophic female adolescents with a high percentage of body fat. Appl Physiol Nutr Metab. (2010) 35:464–70. doi: 10.1139/H10-033
9. Serrano H, Carvalho G, Pereira P, Peluzio Mdo C, Franceschini Sdo C, Priore S. Body composition, biochemical and clinical changes of adolescents with excessive adiposity. Arq Bras Cardiol. (2010) 95:464–72. doi: 10.1590/s0066-782x2010005000109
10. Pereira P, Serrano H, Carvalho G, Lamounier J, Peluzio Mdo C, Franceschini Sdo C, et al. Body fat location and cardiovascular disease risk factors in overweight female adolescents and eutrophic female adolescents with a high percentage of body fat. Cardiol Young. (2012) 22:162–9. doi: 10.1017/S1047951111001430
11. Bragança M, Oliveira B, Fonseca J, Batalha M, Bogea E, Coelho C, et al. Assessment of blood biomarkers in adolescents classified by body mass index and body fat percentage. Cad Saude Publica. (2020) 36:e00084719. doi: 10.1590/0102-311X00084719
12. Wu A, Rifas-Shiman S, Taveras E, Oken E, Hivert M. Associations of DXA-measured abdominal adiposity with cardio-metabolic risk and related markers in early adolescence in Project Viva. Pediatr Obes. (2020) 16:e12704. doi: 10.1111/ijpo.12704
13. García-Hermoso A, Agostinis-Sobrinho C, Camargo-Villalba G, González-Jiménez N, Izquierdo M, Correa-Bautista J, et al. Normal-weight obesity is associated with poorer cardiometabolic profile and lower physical fitness levels in children and adolescents. Nutrients. (2020) 12:1171. doi: 10.3390/nu12041171
14. Cota B, Suhett L, Leite N, Pereira P, Ribeiro S, Franceschini S. Cardiometabolic risk and health behaviours in adolescents with normal-weight obesity: A systematic review. Public Health Nutr. (2020) 24:870–81. doi: 10.1017/S1368980020004863
15. Pettersson-Pablo P, Nilsson T, Breimer L, Hurtig-Wennlöf A. Body fat percentage is more strongly associated with biomarkers of low-grade inflammation than traditional cardiometabolic risk factors in healthy young adults - The Lifestyle, Biomarkers, and Atherosclerosis study. Scand J Clin Lab Invest. (2019) 79:182–7. doi: 10.1080/00365513.2019.1576219
16. Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. (2018) 48:e12997. doi: 10.1111/eci.12997
17. Pettersson-Pablo P, Cao Y, Bäckström T, Nilsson T, Hurtig-Wennlöf A. Body fat percentage and CRP correlates with a composite score of vascular risk markers in healthy, young adults - The lifestyle, biomarkers, and atherosclerosis (LBA) study. BMC Cardiovasc Disord. (2020) 20:77. doi: 10.1186/s12872-020-01376-6
18. Christen T, Trompet S, Rensen P, Willems van Dijk K, Lamb HJ, Jukema JW, et al. The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis. Nutr Metab Cardiovasc Dis. (2019) 29:728–35. doi: 10.1016/j.numecd.2019.03.010
19. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71
20. Sodre M, Ferreira A, Ferreira A. Relação entre concentrações séricas de ácido úrico, resistência insulínica e alterações metabólicas em adolescentes. J Bras Patol Med Lab. (2021) 57:1–7. doi: 10.5935/1676-2444.20210020
21. Harrer M, Furukawa T, Ebert D. Chapter 4 Pooling Effect Sizes. Doing Meta-Analysis in R. Milton Park: Taylor & Francis eBooks (2021).
22. Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. (2019) 22:153–60. doi: 10.1136/ebmental-2019-300117
23. Baujat B, Mahé C, Pignon J, Hill C. A graphical method for exploring heterogeneity in meta-analyses: Application to a meta-analysis of 65 trials. Stat Med. (2002) 21:2641–52. doi: 10.1002/sim.1221
24. Moola, S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic Reviews of Etiology and Risk. In JBI Manual for Evidence Synthesis. (2020). doi: 10.46658/JBIMES-24-06
25. Shea B, Reeves B, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. (2017) 358:4008. doi: 10.1136/bmj.j4008
26. Brandão C, Lombardi M, Nishida S, Hauache O, Vieira J. Serum leptin concentration during puberty in healthy nonobese adolescents. Braz J Med Biol Res. (2003) 36:1293–6. doi: 10.1590/s0100-879x2003001000003
27. Coutinho P, Leite N, Lopes W, da Silva L, Consentino C, Araújo C, et al. Association between adiposity indicators, metabolic parameters and inflammatory markers in a sample of female adolescents. Arch Endocrinol Metab. (2015) 59:325–35. doi: 10.1590/2359-3997000000070
28. Menezes A, Oliveira P, Wehrmeister F, Gonçalves H, Assunção M, Tovo-Rodrigues L, et al. Association between interleukin-6, C-reactive protein and adiponectin with adiposity: Findings from the 1993 pelotas (Brazil) birth cohort at 18 and 22 years. Cytokine. (2018) 110:44–51. doi: 10.1016/j.cyto.2018.04.020
29. Miranda V, Dos Santos Amorim PR, Bastos RR, Canabrava KLR, Júnior MVM, Faria FR, et al. Association of lifestyle and body composition on risk factors of cardiometabolic diseases and biomarkers in female adolescents. Mediators Inflamm. (2020) 2020:9170640. doi: 10.1155/2020/9170640
30. Caballero A, Bousquet-Santos K, Robles-Osorio L, Montagnani V, Soodini G, Porramatikul S, et al. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care. (2008) 31:576–82. doi: 10.2337/dc07-1540
31. McVean J, Carrel A, Eickhoff J, Allen D. Fitness level and body composition are associated with inflammation in non-obese children. J Pediatr Endocrinol Metab. (2009) 22:153–9. doi: 10.1515/jpem.2009.22.2.153
32. Arsalian S, Suprasongsin C, Kalhan SC, Drash Al, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metabolism. (1998) 47:309–12. doi: 10.1016/s0026-0495(98)90262-1
33. Karen PH, Li KE, Yanbin D, Fortenberry J, Stallmann-Jorgensen I, Guo D, et al. Sex dimorphisms in inflammatory markers and adiposity in African American youth. Int J Pediatr Obes. (2010) 5:327–33. doi: 10.3109/17477160903497019
34. Bundy V, Johnson M, Gutin B, Zhu H, Stallmann-Jorgensen I, Dong Y. Adiponectin moderates the relationship between adiposity and leptin in adolescents regardless of gender or race. J Pediatr Endocrinol Metab. (2011) 24:119–24. doi: 10.1515/jpem.2011.036
35. Huang K, Lue B, Yen R, Shen C, Ho S, Tai T, et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res. (2004) 12:119–24. doi: 10.1038/oby.2004.16
36. Huang K, Lin R, Kormas N, Lee L, Chen C, Gill T, et al. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int J Obes Relat Metab Disord. (2004) 28:470–5. doi: 10.1038/sj.ijo.0802531
37. Wu Y, Chu N, Huang Y, Syu J, Chang JB. BMI body fat mass and plasma leptin level in relation to cardiovascular diseases risk factors among adolescents in Taitung. Obes Res Clin Pract. (2015) 10:432–41. doi: 10.1016/j.orcp.2015.08.009
38. Kuo K, Chen H, Hsiao S, Chu D, Huang S, Huang K, et al. The relationship between anthropometric factors and hyperuricemia in adolescent athletes. Obes Res Clin Pract. (2021) 15:375–80. doi: 10.1016/j.orcp.2021.03.012
39. Vikram N, Misra A, Pandey R, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism. (2004) 53:1336–41. doi: 10.1016/j.metabol.2004.05.010
40. Wärnberg J, Nova E, Moreno L, Romeo J, Mesana M, Ruiz J, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: The AVENA Study. Am J Clin Nutr. (2006) 84:505–12. doi: 10.1093/ajcn/84.3.505
41. Schoppen S, Riestra P, García-Anguita A, López-Simón L, Cano B, de Oya I, et al. Leptin and adiponectin levels in pubertal children: Relationship with anthropometric variables and body composition. Clin Chem Lab Med. (2010) 48:707–11. doi: 10.1515/CCLM.2010.142
42. Kelishadi R, Sharifi M, Khosravi A, Adeli K. Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old. Clin Chem. (2007) 53:456–64. doi: 10.1373/clinchem.2006.073668
43. Mirhosseini N, Shahar S, Ghayour-Mobarhan M, Parizadeh M, Yusoff N, Shakeri M. Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls. Iran J Pediatr. (2012) 22:197–204.
44. Stylianou C, Galli-Tsinopoulou A, Farmakiotis D, Rousso I, Karamouzis M, Koliakos G, et al. Ghrelin and leptin levels in obese adolescents. Relationship with body fat and insulin resistance. Hormones (Athens). (2007) 6:295–303. doi: 10.14310/horm.2002.1111025
45. Błogowska A, Rzepka-Górska I, Krzyzanowska-Swiniarska B. Body composition, dehydroepiandrosterone sulfate and leptin concentrations in girls approaching menarche. J Pediatr Endocrinol Metab. (2005) 18:975–83. doi: 10.1515/jpem.2005.18.10.975
46. Plonka M, Toton-Morys A, Adamski P, Suder A, Bielanski W, Dobrzanska M, et al. Association of the physical activity with leptin blood serum level, body mass indices and obesity in schoolgirls. J Physiol Pharmacol. (2011) 62:647–56.
47. Kruger H, Pretorius R, Schutte A. Stunting, adiposity, and low-grade inflammation in African adolescents from a township high school. Nutrition. (2010) 26:90–9. doi: 10.1016/j.nut.2009.10.004
48. Zeelie A, Moss S, Kruger H. The relationship between body composition and selected metabolic syndrome markers in black adolescents in South Africa: The PLAY study. Nutrition. (2010) 26:1058–64. doi: 10.1016/j.nut.2010.03.001
49. Bugge A, El-Naaman B, McMurray R, Froberg K, Nielsen C, Müller K, et al. Inflammatory markers and clustered cardiovascular disease risk factors in Danish adolescents. Horm Res Paediatr. (2012) 78:288–96. doi: 10.1159/000345546
50. Wen X, Pekkala S, Wang R, Wiklund P, Feng G, Cheng S, et al. Does systemic low-grade inflammation associate with fat accumulation and distribution? A 7-year follow-up study with peripubertal girls. J Clin Endocrinol Metab. (2014) 99:1411–9. doi: 10.1210/jc.2013-3267
51. Hinriksdóttir G, Tryggvadóttir Á, Ólafsdóttir AS, Arngrímsson SÁ. Fatness but not fitness relative to the fat-free mass is related to C-reactive protein in 18 year-old adolescents. PLoS One. (2015) 10:e0130597. doi: 10.1371/journal.pone.0130597
52. Agostinis-Sobrinho C, Vicente S, Kievišienė J, Lopes L, Dâmaso A, Norkiene S, et al. High levels of adiponectin attenuate the detrimental association of adiposity with insulin resistance in adolescents. Nutr Metab Cardiovasc Dis. (2020) 30:822–8. doi: 10.1016/j.numecd.2020.02.011
53. World Health Organization (WHO). Development of a WHO Growth Reference for School-Aged Children and Adolescents. Geneva: World Health Organization (2007).
54. Zhang S, Liu X, Brickman W, Christoffel K, Zimmerman D, Tsai H, et al. Association of plasma leptin concentrations with adiposity measurements in rural Chinese adolescents. J Clin Endocrinol Metab. (2009) 94:3497–504. doi: 10.1210/jc.2009-1060
55. Villarroya F, Cereijo R, Gavaldà-Navarro A, Villarroya J, Giralt M. Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J Intern Med. (2018) 284:492–504. doi: 10.1111/joim.12803
56. Saltiel A, Olefsky J. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. (2017) 127:1–4. doi: 10.1172/JCI92035
57. Carobbio S, Pellegrinelli V, Vidal-Puig A. Adipose tissue function and expandability as determinants of lipotoxicity and the metabolic syndrome. Adv Exp Med Biol. (2017) 960:161–96. doi: 10.1007/978-3-319-48382-5_7
58. Lempesis I, van Meijel R, Manolopoulos K, Goossens G. Oxygenation of adipose tissue: A human perspective. Acta Physiol (Oxf). (2020) 228:e13298. doi: 10.1111/apha.13298
59. Chait A, den Hartigh L. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. (2020) 7:22. doi: 10.3389/fcvm.2020.00022
60. Francisco G, Hernández C, Simó R. Serum markers of vascular inflammation in dyslipemia. Clin Chim Acta. (2006) 369:1–16. doi: 10.1016/j.cca.2005.12.027
61. Rexrode K, Pradhan A, Manson J, Buring J, Ridker P. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. (2003) 13:674–82. doi: 10.1016/s1047-2797(03)00053-x
62. Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A, et al. IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: The STANISLAS cohort. Atherosclerosis. (2003) 170:277–83. doi: 10.1016/s0021-9150(03)00287-9
63. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab. (2010) 95:1060–8. doi: 10.1210/jc.2009-1887
64. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett. (2005) 26:473–9.
65. Frühbeck G, Catalán V, Rodríguez A, Ramírez B, Becerril S, Salvador J, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. (2019) 11:454. doi: 10.3390/nu11020454
66. Fujita Y, Kouda K, Ohara K, Nakamura H, Iki M. Leptin mediates the relationship between fat mass and blood pressure: The Hamamatsu School-based health study. Medicine (Baltimore). (2019) 98:e14934. doi: 10.1097/MD.0000000000014934
67. Gonzaga N, Medeiros C, de Carvalho D, Alves J. Leptin and cardiometabolic risk factors in obese children and adolescents. J Paediatr Child Health. (2014) 50:707–12. doi: 10.1111/jpc.12610
68. Shehzad A, Iqbal W, Shehzad O, Lee Y. Adiponectin: Regulation of its production and its role in human diseases. Hormones (Athens). (2012) 11:8–20. doi: 10.1007/BF03401534
69. Gilardini L, McTernan P, Girola A, da Silva N, Alberti L, Kumar S, et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis. (2006) 189:401–7. doi: 10.1016/j.atherosclerosis.2005.12.021
70. González M, del Mar Bibiloni M, Pons A, Llompart I, Tur JA. Inflammatory markers and metabolic syndrome among adolescents. Eur J Clin Nutr. (2012) 66:1141–5. doi: 10.1038/ejcn.2012.112
71. Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. (2007) 34:18–22. doi: 10.1016/j.ejvs.2006.10.040
72. Raposeiras Roubín S, Barreiro Pardal C, Roubín-Camiña F, Ocaranza Sanchez R, Alvarez Castro E, Paradela Dobarro B, et al. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction. Rev Port Cardiol. (2013) 32:117–22. doi: 10.1016/j.repc.2012.05.026
73. Hagman E, Besor O, Hershkop K, Santoro N, Pierpont B, Mata M, et al. Relation of the degree of obesity in childhood to adipose tissue insulin resistance. Acta Diabetol. (2019) 56:219–26. doi: 10.1007/s00592-018-01285-3
74. de F Rocha AR, de S Morais N, Priore SE, do C C Franceschini S. Inflammatory biomarkers and components of metabolic syndrome in adolescents: A systematic review. Inflammation. (2021) 45:14–30. doi: 10.1007/s10753-021-01549-1
75. Foster C, Smith L, Alemzadeh R. Excess serum uric acid is associated with metabolic syndrome in obese adolescent patients. J Diabetes Metab Disord. (2020) 19:535–43. doi: 10.1007/s40200-020-00507-2
76. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti G, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. (2019) 20:2358. doi: 10.3390/ijms20092358
77. Cucoreanu C, Tigu A, Nistor M, Moldovan R, Pralea I, Iacobescu M, et al. Epigenetic and molecular alterations in obesity: Linking CRP and DNA methylation to systemic inflammation. Curr Issues Mol Biol. (2024) 46:7430–46. doi: 10.3390/cimb46070441
Keywords: adipose tissue, adolescence, body composition, inflammatory markers, cardiometabolic risk
Citation: Rocha ARF, Morais NS, Azevedo FM, Morais DC, Pereira PF, Peluzio MCG, Franceschini SCC and Priore SE (2025) Leptin, CRP, and adiponectin correlate with body fat percentage in adolescents: systematic review and meta-analysis. Front. Nutr. 12:1560080. doi: 10.3389/fnut.2025.1560080
Received: 13 January 2025; Accepted: 10 June 2025;
Published: 11 July 2025.
Edited by:
Xiaoxing Kou, Sun Yat-sen University, ChinaReviewed by:
Nagasuryaprasad Kotikalapudi, Beth Israel Deaconess Medical Center and Harvard Medical School, United StatesBing Bo, Henan University, China
Sandeep Kumar Swain, ICMR-National Institute of Child Health and Development Research, India
Copyright © 2025 Rocha, Morais, Azevedo, Morais, Pereira, Peluzio, Franceschini and Priore. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ariane Ribeiro de Freitas Rocha, YXJpYW5lLmZyZWl0YXNAdWZ2LmJy